MedTrace Logo

Clinical Evaluation of the BlueDop Vascular Expert for Assessing Peripheral Arterial Disease

NCT05073510 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 187

Last updated 2024-12-27

Study results available
· View outcomes & findings →

Summary

This is a BlueDop Vascular Expert System (BVE) Post-Market Clinical Follow-Up (PMCF) study. The primary objective of the study is to assess the clinical applicability and diagnostic accuracy of the BVE device in subjects who require an arterial duplex test due to suspected peripheral arterial disease (PAD).

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

BVE

Participants will undergo BVE evaluation for assessing Peripheral Arterial Disease (PAD)

Sponsors & Collaborators

  • AKRN Scientific Consulting, S.L.

    collaborator INDUSTRY

  • BlueDop Medical LTD

    lead INDUSTRY

Principal Investigators

  • José Ignacio Leal Lorenzo · Clínica Universidad de Navarra

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-11
Primary Completion
2023-09-11
Completion
2023-09-11

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05073510 on ClinicalTrials.gov